If I stop Hyzaar (losartan + hydrochlorothiazide) in an adult patient who is currently controlled on it, will I experience rebound hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

No Rebound Hypertension with Hyzaar Discontinuation

You will not experience rebound hypertension if you stop Hyzaar (losartan/hydrochlorothiazide). The evidence consistently demonstrates that ARBs like losartan do not cause rebound hypertension upon discontinuation, unlike certain other antihypertensive classes.

Evidence from Clinical Trials

The FDA label for Hyzaar explicitly states: "There is no apparent rebound effect after abrupt withdrawal of losartan" 1. This finding was confirmed in controlled clinical trials where withdrawal effects such as rebound hypertension were not observed 2.

A dedicated study specifically evaluated this concern by monitoring blood pressure during a 1-week off-drug period after 12 weeks of losartan treatment. The investigators found no evidence of rebound hypertension during withdrawal 3. This was a prospective assessment designed to detect this specific complication.

Important Contrast with Other Medications

The 2025 AHA/ACC hypertension guidelines make a critical distinction: certain medications like beta-blockers and clonidine may cause rebound hypertension if discontinued abruptly, but ARBs are not in this category 4. The guideline specifically warns that "abrupt pre-operative discontinuation of BB or clonidine may result in rebound hypertension and is potentially harmful" (Class 3: Harm recommendation) 4.

Losartan/HCTZ does not share this risk profile.

What Actually Happens When You Stop

When you discontinue Hyzaar:

  • Your blood pressure will gradually return toward baseline levels over days to weeks
  • This is not rebound hypertension—it's simply loss of therapeutic effect
  • The rise is gradual and predictable, not the sudden, dangerous spike seen with beta-blocker or clonidine withdrawal
  • No special tapering protocol is required for ARBs

Clinical Implications

If you need to stop Hyzaar for any reason (surgery, side effects, medication change):

  • You can stop it abruptly without fear of rebound hypertension
  • Your blood pressure should be monitored as it will rise back to untreated levels
  • Alternative antihypertensive therapy should be initiated if ongoing BP control is needed
  • This is fundamentally different from medications that require tapering

The safety profile of losartan withdrawal has been confirmed across multiple studies involving thousands of patients, with consistent findings of excellent tolerability and no withdrawal phenomena 2.

References

Related Questions

What is the optimal blood pressure management strategy for a 67-year-old patient currently on losartan 100 mg daily and hydrochlorothiazide (HCTZ) 25 mg daily?
Can I switch from lisinopril 40 mg plus hydrochlorothiazide 50 mg to losartan 100 mg/hydrochlorothiazide 50 mg (Hyzaar) to better control uncontrolled hypertension?
Is it safe to combine hydrochlorothiazide, losartan, diltiazem (Procardia), and hydralazine?
How should I manage a patient on Hyzaar (losartan/hydrochlorothiazide) who is experiencing hypotension, fatigue, and dehydration?
How can the losartan (angiotensin II receptor blocker) dose be increased while keeping the hydrochlorothiazide dose unchanged in a patient currently on losartan 50 mg/hydrochlorothiazide 12.5 mg?
In a 42-year-old woman with acute oliguric renal failure three days after initiating chemotherapy for newly diagnosed non‑Hodgkin lymphoma, whose urine sediment shows amber hexagonal plate, barrel, and needle crystals, which of the following therapies is least likely to be beneficial for managing acute uric‑acid nephropathy (tumor‑lysis syndrome): rasburicase, aggressive intravenous hydration, allopurinol, or sodium bicarbonate?
Is eating 24.5 g of dairy milk chocolate daily safe for a patient with hypertension?
How should I interpret a urinalysis with glucosuria, proteinuria, alkaline pH 8.5, turbid appearance, normal specific gravity, minimal white and red blood cells, rare bacteria, and a high number of squamous epithelial cells, and what are the appropriate next steps?
What considerations should be taken into account when treating obesity with GLP‑1 receptor agonists in patients with stable congestive heart failure (NYHA class I‑II), including dosing, titration, monitoring, and management of potential hypotension or volume depletion?
Can a patient who recently had a large abdominal surgery and has a history of major depressive disorder safely begin transcranial magnetic stimulation (TMS) now?
How should I manage a patient on Hyzaar (losartan/hydrochlorothiazide) who is experiencing hypotension, fatigue, and dehydration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.